November 22nd 2024
At least 1 accurate UTI symptom was found on most of the 331 websites reviewed, but nearly all (80%) included at least 1 inaccurate or misleading one.
November 20th 2024
The recommendations from WikiGuidelines are the first for UTI prevention, diagnosis, and management in over a decade.
Analysis of surveillance data revealed a decline in use of antiviral medications for children hospitalized with influenza and prevalent underprescribing in outpatient settings.
November 13th 2024
More than 2.4 million STIs were reported in the US in 2023 — a 1.8% decrease from 2022, according to the CDC's annual STI report.
November 12th 2024
The FDA cleared Novavax to start enrolling the planned phase 3 trial after a safety concern was found to be unrelated to the combination vaccine.
Patient, Provider, and Caregiver Connection™: Prevention and Control of Meningococcal Disease — Individualizing Vaccine Recommendations in Adolescent Populations
View More
Cases and Conversations™: Applying Best Practices to Prevent Shingles in Your Practice
COVID-19 Updates: Delta Variant, US Vaccinations, & Global Data as of October 27, 2021
Data from the CDC on the Delta variant and US vaccination rates and from the Johns Hopkins COVID-19 interactive map on cases and deaths in the US and worldwide.
COVID-19 Updates: Delta Variant, US Vaccinations, & Global Data as of October 26, 2021
COVID-19 Updates: Delta Variant, US Vaccinations, & Global Data as of October 25, 2021
Moderna Says COVID-19 Vaccine Triggers Strong Immune Response in Children Aged 6-11 Years
Two doses of Moderna's COVID-19 vaccine showed robust neutralizing antibody titers in children aged 6 to 11 years, the company announced on Monday.
COVID-19 Updates: Delta Variant, US Vaccinations, & Global Data as of October 21, 2021
FDA Greenlights Mixing COVID-19 Boosters and Moderna, J&J Booster Shots
CDC vaccine advisors will meet Thursday to discuss final approval of booster doses of Moderna and J&J vaccines and mix-and-match approach authorized by FDA.
COVID-19 Updates: Delta Variant, US Vaccinations, & Global Data as of October 20, 2021
COVID-19 Updates: Delta Variant, US Vaccinations, & Global Data as of October 19, 2021
COVID-19 Updates: Delta Variant, US Vaccinations, & Global Data as of October 18, 2021
A Drive-through Flu Shot Clinic: Is it Time to Try One?
The traditional flu shot clinic with waiting rooms full won't work this year. One practice planned its own drive-through flu vaccination clinic. Here's how.
COVID-19 Updates: Delta Variant, US Vaccinations, & Global Data as of October 15, 2021
COVID-19 Updates: Delta Variant, US Vaccinations, & Global Data as of October 14, 2021
COVID-19 Updates: Delta Variant, US Vaccinations, & Global Data as of October 13, 2021
COVID-19 Updates: Delta Variant, US Vaccinations, & Global Data as of October 8, 2021
AstraZeneca Submits Request for EUA for COVID-19 Prophylaxis, AZD7442
This week, AstraZeneca submitted a request to the FDA for an emergency use authorization for their long-acting antibody cocktail for prophylaxis of COVID-19.
COVID-19 Updates: Delta Variant, US Vaccinations, & Global Data as of October 7, 2021
COVID-19 Updates: Delta Variant, US Vaccinations, & Global Data as of October 6, 2021
COVID-19 Updates: Delta Variant, US Vaccinations, & Global Data as of October 5, 2021
COVID-19 Lockdown Had Significant, Yet Varying, Impact on Glycemic Control
EASD 2021: First analysis of its kind found COVID-19-induced lockdown was associated with improved glycemic control among patients with T1D, but not T2D.
COVID-19 Updates: Delta Variant, US Vaccinations, & Global Data as of October 4, 2021
The number of US confirmed deaths has surpassed 702 000. Plus more data on the Delta variant, cases, mortalities, and vaccination in our daily update.
COVID-19 Updates: Delta Variant, US Vaccinations, & Global Data as of October 1, 2021
Merck Oral Antiviral Reduces by Half the Risk of COVID-19 Hospitalization, Death in Vulnerable Adults
The positive results of the Merck MOVe-OUT phase 3 interim analysis of molnupiravir have led to an early halt to study recruitment, the company said Friday.
People Living with HIV Use Fewer Essential Clinical Services and Less Frequently During Pandemic
Viral-load monitoring rates decreased and clinic visits declined overall despite an increase in use of telehealth.
COVID-19 Updates: Delta Variant, US Vaccinations, & Global Data as of September 30, 2021
Health Care Workers Likely to Recommend COVID-19 Vaccine to Patients Based on Safety Messaging, Survey Finds
Survey authors said findings merit further research into how to increase health care workers' confidence in discussing and recommending COVID-19 vaccines with patients.
Obesity May Put Children Hospitalized with COVID-19 at Higher Risk for Severe Disease, Suggests New Study
IDWeek 2021: Obesity prevention and vaccination efforts may help prevent COVID-19-related morbidity in pediatric COVID-19 patients with obesity, noted authors of a new study.
COVID-19 Updates: Delta Variant, US Vaccinations, & Global Data as of September 29, 2021
Low Prevalence of COVID-19 and Flu Coinfection Found in Real-world Cohort Study
Coinfection with influenza virus among COVID-19 patients was found to be rare in a new study presented at IDWeek 2021.
IDWeek 2021: C diff Clinical Outcomes Unchanged after 2017 IDSA Guideline Update
IDWeek 2021: Use of vancomycin vs metronidazole increased after the 2017 IDSA recommendation but CDI recurrence rates increased slightly, investigators report.
COVID-19 Updates: Delta Variant, US Vaccinations, & Global Data as of September 28, 2021